Company: PIII
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001832511-25-000013
Chunk: 88

Company: P3 Health Partners Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 88
---
uted$(6.23)$(7.37)$(12.52)$(15.19)WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (Note 9):Basic3,267 2,732 3,263 2,556 Diluted3,267 2,822 3,263 2,601 

All periods presented have been retroactively adjusted to reflect the 1-for-50 reverse stock split effected on April 11, 2025. See Note 3 “Significant Accounting Policies” for further information.  

See accompanying notes to condensed consolidated financial statements.

P3 Health Partners Inc. | Q2 2025 Form 10-Q | 6

P3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND MEZZANINE EQUITY

(in thousands)

(unaudited)

RedeemableNon-controllingInterestClass A Common StockClass V Common StockAdditional Paid in CapitalAccumulatedDeficitTotal Stockholders’EquitySharesAmountSharesAmountSTOCKHOLDERS’ EQUITY, December 31, 2023$291,532 2,331$— 3,932$— $509,474 $(367,344)$142,130 Exchanges of redeemable non-controlling interest for Class A common stock— 2 — (2)— — — — Issuance of Class A common stock upon settlement of restricted stock units, net of shares withheld for tax— 55 — — — (73)— (73)Equity-based compensation— — — — — 1,449 — 1,449 Fair value adjustment to redeemable non-controlling interest(20,579)— — — — 20,579 — 20,579 Remeasurement adjustment to redeemable non-controlling interest resulting from ownership changes(1,211)— — — — 1,211 — 1,211 Net loss(30,906)— — — — — (18,700)(18,700)STOCKHOLDERS’ EQUITY, March 31, 2024$238,836 2,388 $— 3,930 $— $532,640 $(386,044)$146,596